Impact of iodine contrast media on gamma camera-based GFR and factors affecting the difference between serum creatinine-based estimated GFR and Gate's GFR

被引:0
作者
Ishii, Shiro [1 ]
Sugawara, Shigeyasu [1 ]
Tanaka, Yumi [1 ]
Kawamoto, Natsumi [1 ]
Hara, Junko [1 ]
Yamakuni, Ryo [1 ]
Suenaga, Hiroki [1 ]
Fukushima, Kenji [1 ]
Ito, Hiroshi [1 ]
机构
[1] Fukushima Med Univ, Dept Radiol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan
关键词
estimated GFR; Gates' method; glomerular filtration rate; serum creatinine clearance; Tc-99m-DTPA; GLOMERULAR-FILTRATION-RATE; CYSTATIN-C; PLASMA SAMPLE; KIDNEY DONORS; EQUATION; CLEARANCE; UPDATE; MARKER;
D O I
10.1097/MNM.0000000000001848
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective We aimed to elucidate the factors underlying the difference between estimated glomerular filtration rate (eGFR) calculated from serum creatinine and Gate's GFR (gGFR) measured using technetium-99m diethylene triamine pentaacetic acid (Tc-99m-DTPA) scintigraphy. Methods This study was based on consecutive patients who underwent Tc-99m-DTPA scintigraphy at our hospital between January 2021 and December 2022 and whose blood serum creatinine data were obtained on the same day as the Tc-99m-DTPA scintigraphy. Relationships between the ratio of gGFR and eGFR (gGFR/eGFR) and age, sex, BMI, visceral fat, psoas muscle index (PMI), serum blood urea nitrogen, and creatinine level were investigated based on 75 patients. Additionally, for 44 patients who had two or more follow-up DTPA studies, we compared gGFR values for studies that used iodine contrast media (ICM) for computed tomography before same-day Tc-99m-DTPA studies and those that did not in the same patients. Results Weak correlations were observed between gGFR/eGFR and PMI (r = 0.30), BMI (r = 0.24), and the visceral fat area (r = 0.33). Multi-regression analyses showed that gGFR/eGFR was correlated with PMI (beta = 0.34, P < 0.01) and approached significance with the visceral fat area (beta = 0.24, P = 0.05). A significant difference was observed in gGFR between patients who received ICM before the Tc-99m-DTPA renogram and those who did not (P < 0.001, eGFR 80.5 +/- 19.0 vs. 91.7 +/- 27.8 ml/min). Conclusion ICM administration temporarily decreased gGFR, and increased muscle mass increased the difference between eGFR and gGFR values.
引用
收藏
页码:573 / 580
页数:8
相关论文
共 40 条
[1]  
ACR Committee on Drugs and Contrast Media, 2020, ACR MAN CONTR MED
[2]  
Andreucci M, 2017, DRUG HEALTHC PATIENT, V9, P25, DOI 10.2147/DHPS.S122207
[3]   Evaluation of the renal parenchymal retention of iodinated contrast agent during follow-up computed tomography performed one day after undergoing contrast-enhanced computed tomography [J].
Ariyoshi, Shoko ;
Tanabe, Masahiro ;
Ito, Katsuyoshi .
EUROPEAN JOURNAL OF RADIOLOGY, 2020, 132
[4]  
Aydin F, 2008, NUCL MED COMMUN, V29, P157
[5]   Cystatin C as a biomarker of chronic kidney disease: latest developments [J].
Benoit, Stefanie W. ;
Ciccia, Eileen A. ;
Devarajan, Prasad .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (10) :1019-1026
[6]   Renal function in children and adolescents with Duchenne muscular dystrophy [J].
Braat, Bike ;
Hoste, Liesbeth ;
De Waele, Liesbeth ;
Gheysens, Olivier ;
Vermeersch, Pieter ;
Goffin, Karolien ;
Pottel, Hans ;
Goemans, Nathalie ;
Levtehenko, Elena .
NEUROMUSCULAR DISORDERS, 2015, 25 (05) :381-387
[7]   Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients [J].
Cimerman, N ;
Brguljan, PM ;
Krasovec, M ;
Suskovic, S ;
Kos, J .
CLINICA CHIMICA ACTA, 2000, 300 (1-2) :83-95
[8]   Update and review of contrast-associated acute kidney injury [J].
Colbert, Gates B. ;
Patel, Trisha K. ;
Gaddy, Anna ;
Lerma, Edgar .
DM DISEASE-A-MONTH, 2022, 68 (01)
[9]   CYSTATIN-C LEVELS IN SERA OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A NEW AVIDIN-BIOTIN ELISA ASSAY FOR ITS MEASUREMENT [J].
COLLE, A ;
TAVERA, C ;
PREVOT, D ;
LEUNGTACK, J ;
THOMAS, Y ;
MANUEL, Y ;
BENVENISTE, J ;
LEIBOWITCH, J .
JOURNAL OF IMMUNOASSAY, 1992, 13 (01) :47-60
[10]   Pharmacology, Part 5: CT and MRI Contrast Media [J].
Currie, Geoffrey M. .
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2019, 47 (03) :189-202